Sequencing — Total Revenue
Illumina Sequencing — Total Revenue decreased by 6.7% to $995.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.1%, from $947.00M to $995.00M. Over 4 years (FY 2021 to FY 2025), Sequencing — Total Revenue shows relatively stable performance with a -0.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing adoption of genomic sequencing technology and successful expansion of the installed base, while a decrease may signal market saturation or increased competition in the life sciences tools sector.
Detailed definition
This metric represents the total gross revenue generated by the core sequencing business segment, encompassing sales of...
Peer comparison
Comparable to 'Life Sciences Tools' or 'Genomics' segment revenues reported by peers like Thermo Fisher or Pacific Biosciences.
ilmn_segment_sequencing_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.02B | $1.02B | $1.09B | $1.11B | $1.07B | $1.02B | $981.00M | $976.00M | $1.08B | $1.03B | $1.02B | $979.00M | $1.02B | $995.00M | $1.00B | $947.00M | $972.00M | $1.00B | $1.07B | $995.00M |
| QoQ Change | — | -0.6% | +7.8% | +1.4% | -4.0% | -4.7% | -3.3% | -0.5% | +11.0% | -5.0% | -0.5% | -4.4% | +3.8% | -2.1% | +0.9% | -5.7% | +2.6% | +3.0% | +6.5% | -6.7% |
| YoY Change | — | — | — | — | +4.3% | +0.0% | -10.3% | -12.0% | +1.7% | +1.4% | +4.4% | +0.3% | -6.2% | -3.3% | -2.0% | -3.3% | -4.3% | +0.6% | +6.2% | +5.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Illumina's sequencing — total revenue?
- Illumina (ILMN) reported sequencing — total revenue of $995.00M in Q1 2026.
- How has Illumina's sequencing — total revenue changed year-over-year?
- Illumina's sequencing — total revenue increased by 5.1% year-over-year, from $947.00M to $995.00M.
- What is the long-term trend for Illumina's sequencing — total revenue?
- Over 4 years (2021 to 2025), Illumina's sequencing — total revenue has grown at a -0.8% compound annual growth rate (CAGR), from $4.11B to $3.99B.
- What does sequencing — total revenue mean?
- The total amount of money earned from the sale of genetic sequencing products and services.